Physician profile
James B Mueller
NPI 1730135914
$635,522.56
in general payments reported to CMS, 2019-2025
11 companies · $95K in 2025
The $95K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $16K · 2021: $63K · 2022: $127K · 2023: $101K · 2024: $143K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $143K · Honoraria: $139K · Travel and Lodging: $52K · Food and Beverage: $5,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $143,160.00 |
| Honoraria | $138,710.00 |
| Travel and Lodging | $51,752.01 |
| Food and Beverage | $5,295.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $634,692.26 | 2019-2025 | Exparel, Iovera, Zilretta |
| Csl Behring | $238.04 | 2019-2022 | |
| Medtronic, INC. | $163.60 | 2021 | |
| Grifols USA, LLC | $117.30 | 2019 | |
| Pacira Cryotech Incorporated | $104.85 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $84.03 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $48.21 | 2023-2024 | Libtayo |
| Amgen INC. | $23.06 | 2019 | |
| Chiesi USA, INC. | $21.64 | 2023 | Cleviprex, Kengreal |
| Abbott Laboratories | $18.03 | 2019 | |
| Merck Sharp & Dohme LLC | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.